PLYMOUTH
MEETING, Pa., Oct. 1, 2024
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company
focused on developing and commercializing DNA medicines to help
treat and protect people from HPV-related diseases, cancer, and
infectious diseases, today announced that it will present at
the following scientific conferences:
AACR Special Conference in Cancer Research:
Tumor Immunology and Immunotherapy
Poster by Dr.
Matthew Morrow, VP of Translational
Sciences at INOVIO
Abstract Title: Reduction in Surgical Interventions
for the Treatment of Recurrent Respiratory Papillomatosis by
INO-3107 is Associated with Enriched Macrophage, Dendritic cell and
T cell Signatures in Patient Airways
Date and Time:
October 19, 2024, 6:00 - 8:15pm ET
Location:
Boston, MA
ISV Congress 2024
Oral presentation
and poster by Dr. Michael Sumner,
Chief Medical Officer at INOVIO
Abstract Title: Clinical Assessment of Adjuvant Immunotherapy,
INO-3107, in Adult Patients with Recurrent Respiratory
Papillomatosis (RRP)
Date and Time: October 22, 2024, 4:20pm KST
Location: Seoul, Korea
Fall Voice
Poster by Dr. Jeffrey Skolnik, SVP of Clinical Development at
INOVIO
Abstract Title: Clinical Assessment of Adjuvant Immunotherapy,
INO-3107, in Adult Patients with Recurrent Respiratory
Papillomatosis (RRP)
Date and Time: October 25 – October 26,
2024
Location: Phoenix,
AZ
World Vaccine Congress
Europe
Presentation and panel discussion by Dr.
Dave Liebowitz, SVP Early-Stage Clinical
Development at INOVIO
Track: Pre-Congress Workshop on Platform Technologies
Date and Time: October 28, 2024,
10:00am CET
Location: Barcelona, Spain
Abstracts from these conferences will be made available on
INOVIO's website following each presentation.
About INOVIO
INOVIO is a biotechnology company
focused on developing and commercializing DNA medicines to help
treat and protect people from HPV-related diseases,
cancer, and infectious diseases. INOVIO's technology
optimizes the design and delivery of innovative DNA medicines that
teach the body to manufacture its own disease-fighting tools. For
more information, visit www.inovio.com.
Contacts
Media: Jennie
Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267)
440-4298 thomas.hong@inovio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inovio-to-present-at-upcoming-scientific-conferences-302263723.html
SOURCE INOVIO Pharmaceuticals, Inc.